These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1290 related articles for article (PubMed ID: 17982350)

  • 41. [Management of glucocorticoid-induced osteoporosis in childhood].
    Tanaka H
    Clin Calcium; 2006 Nov; 16(11):1879-86. PubMed ID: 17079856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Male osteoporosis: current treatments and future options].
    Romagnoli E; Paglia F; Dionisi S; De Geronimo S; Pepe J; Di Virgilio R; Minisola S
    Clin Ter; 2003; 154(1):49-53. PubMed ID: 12854284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients.
    Yosipovitch G; Hoon TS; Leok GC
    Arch Dermatol; 2001 Apr; 137(4):477-81. PubMed ID: 11295929
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Glucocorticoid induced osteoporosis].
    Lange U; Müller-Ladner U
    Orthopade; 2007 Apr; 36(4):381-8; quiz 389-90. PubMed ID: 17665509
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glucocorticoid-induced osteoporosis in inflammatory bowel disease.
    Lidofsky S; Smith J
    Med Health R I; 2009 Apr; 92(4):128-30. PubMed ID: 19452756
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessing fracture risk and effects of osteoporosis drugs: bone mineral density and beyond.
    Davison KS; Kendler DL; Ammann P; Bauer DC; Dempster DW; Dian L; Hanley DA; Harris ST; McClung MR; Olszynski WP; Yuen CK
    Am J Med; 2009 Nov; 122(11):992-7. PubMed ID: 19854322
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Secondary osteoporosis. Glucocorticoid-induced osteoporosis: Threshold of bone mineral density for vertebral fracture].
    Soen S
    Clin Calcium; 2007 Mar; 17(3):399-402. PubMed ID: 17339745
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Glucocorticoid-induced osteoporosis: recent findings].
    Angeli A; Osella G; Reimondo G; Terzolo M
    Ann Ital Med Int; 2000; 15(1):47-55. PubMed ID: 10842891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bisphosphonates and glucocorticoid-induced osteoporosis: cons.
    Lems WF; Saag K
    Endocrine; 2015 Aug; 49(3):628-34. PubMed ID: 26041376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug insight: the use of bisphosphonates for the prevention and treatment of osteoporosis in men.
    Brown SA; Guise TA
    Nat Clin Pract Urol; 2007 Jun; 4(6):310-20. PubMed ID: 17551535
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glucocorticoid-induced osteoporosis.
    Reid IR
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Jun; 14(2):279-98. PubMed ID: 11035907
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Glucocorticoid-induced osteoporosis: review and proposition for prevention and treatment guidelines].
    Grazio S; Korsić M; Anić B; Vitezić-Misjak M; Grubisić F
    Lijec Vjesn; 2005; 127(1-2):36-43. PubMed ID: 16145872
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Secondary osteoporosis. Pathogenesis of glucocorticoid-induced osteoporosis].
    Takayanagi R
    Clin Calcium; 2007 Feb; 17(2):270-4. PubMed ID: 17272886
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Glucocorticoid induced osteoporosis in childhood: prophylaxis and treatment].
    Tanaka H
    Clin Calcium; 2009 Apr; 19(4):569-73. PubMed ID: 19329838
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recurrent fractures in an elderly patient with systemic lupus erythematosus.
    Chia FL; Thong BY; Lau TC; Feng PH
    Int J Rheum Dis; 2009 Sep; 12(3):256-63. PubMed ID: 20374356
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Secondary osteoporosis. A review of recent evidence focusing on glucocorticoid-induced osteoporosis and osteoporosis associated with rheumatoid arthritis].
    Suzuki Y
    Clin Calcium; 2007 Jan; 17(1):104-7. PubMed ID: 17211102
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Biochemical markers of bone turnover. New aspect. Biochemical bone markers of bone in patients treated with glucocorticoid].
    Yamauchi M
    Clin Calcium; 2009 Aug; 19(8):1092-1100. PubMed ID: 19638692
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis.
    van Staa TP
    Calcif Tissue Int; 2006 Sep; 79(3):129-37. PubMed ID: 16969593
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.
    van Staa TP; Leufkens HG; Cooper C
    Osteoporos Int; 2002 Oct; 13(10):777-87. PubMed ID: 12378366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Idiopathic and secondary osteoporosis in childhood].
    Rossi F; Perrotta S; Falcone E; Gimigliano F; Iodice M; Vetrella S; Iolascon G
    Minerva Pediatr; 2005 Oct; 57(5):203-11. PubMed ID: 16205605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.